Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 2/20 | 0.75 |
| ▸ | CA1 | P00915 | 1/20 | 0.75 |
| ▸ | CA2 | P00918 | 1/20 | 0.75 |
| ▸ | CA4 | P22748 | 1/20 | 0.75 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.65 |
| ▸ | TNKS | O95271 | 1/20 | 0.65 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.65 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.65 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.65 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.65 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.65 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.65 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.65 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.65 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.65 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.65 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.65 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.65 |
| ▸ | HTT | P42858 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL69543 | 1.00 | NFKB1 (0.75) | NFKB1CA1CA2CA4HDAC3 | |
| SCHEMBL31197561 | 1.00 | NFKB1 (0.75) | NFKB1CA1CA2CA4HDAC3 | |
| Bromide SCHEMBL8376004 | 0.97 | NFKB1 (0.72) | NFKB1CA1CA2CA4HDAC3 | |
| Hydrochloric Acid SCHEMBL8374050 | 0.97 | NFKB1 (0.72) | NFKB1CA1CA2CA4HDAC3 | |
| SCHEMBL2313844 | 0.91 | NFKB1 (0.64) | NFKB1CA1CA2CA4HDAC3 | |
| SCHEMBL11121643 | 0.91 | HCAR2 (0.75) | NFKB1CA1CA2CA4HDAC3 | |
| SCHEMBL30451096 | 0.91 | NFKB1 (0.64) | NFKB1CA1CA2CA4HDAC3 | |
| SCHEMBL2313840 | 0.91 | NFKB1 (0.64) | NFKB1CA1CA2CA4HDAC3 | |
| SCHEMBL24284657 | 0.89 | NFKB1 (0.62) | NFKB1CA1CA2CA4HDAC3 | |
| SCHEMBL175543 | 0.89 | NFKB1 (0.62) | NFKB1CA1CA2CA4HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 298 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160237073-A1 | Novel Polymorphs and Salts | GLAXO GROUP LTD (GB) | 2016-08-18 | — | — | US | claimed |
| EP-2614058-B1 | POLYMORPHS AND SALTS OF N-[5-[4-(5-{[(2R,6S)-2,6-DIMETHYL-4-MORPHOLINYL]METHYL}-& xA;1,3-OXAZOL-2-YL)-1H-INDAZOL-6-YL]-2-(METHYLOXY)-3-PYRIDINYL]METHANESULFONAMIDE | GLAXOSMITHKLINE IP DEV LTD (GB) | 2015-07-08 | — | — | EP | claimed |
| US-20140256721-A1 | Novel Polymorphs and Salts | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2014-09-11 | — | — | US | claimed |
| EP-2614058-A1 | POLYMORPHS AND SALTS OF N- [5- [4- (5- { [(2R,6S) -2, 6 - DIMETHYL - 4 -MORPHOLINYL]METHYL} - 1, 3 - OXAZOL - 2 - YL) - 1H- INDA ZOL-6-YL]-2- (METHYLOXY) - 3 - PYRIDINYL]METHANESULFONAMIDE | GlaxoSmithKline Intellectual Property Development Limited (GB) | 2013-07-17 | — | — | EP | claimed |
| US-20130165441-A1 | Novel Polymorphs and Salts | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2013-06-27 | — | — | US | claimed |
| WO-2012032067-A1 | POLYMORPHS AND SALTS OF N- [5- [4- (5- { [(2R,6S) -2, 6 - DIMETHYL - 4 -MORPHOLINYL] METHYL} - 1, 3 - OXAZOL - 2 - YL) - 1H- INDA ZOL-6-YL] -2- (METHYLOXY) - 3 - PYRIDINYL] METHANESULFONAMIDE | GLAXO GROUP LIMITED (GB) | 2012-03-15 | — | — | WO | claimed |
| US-7128972-B2 | Wrinkled polyester particles | BANK OF AMERICA, N.A., AS AGENT | 2006-10-31 | — | — | US | claimed |
| EP-1336638-B1 | Method of preparation of porous polyester particles | EASTMAN KODAK CO (US) | 2006-06-07 | — | — | EP | claimed |
| US-6780942-B2 | PREPARING MIXTURE OF ORGANIC PHASE AND AQUEOUS PHASE COMPRISING AN UNSATURATED POLYESTER, A WATER IMMISCIBLE SOLVENT, AN ORGANIC-SOLUBLE ETHYLENICALLY UNSATURATED MONOMER, AND INITIATOR, EMULSIFYING, CROSSLINKING | EASTMAN KODAK COMPANY | 2004-08-24 | — | — | US | claimed |
| US-20040023027-A1 | Wrinkled polyester particles | EASTMAN KODAK COMPANY | 2004-02-05 | — | — | US | claimed |
| WO-1989001006-A1 | UNSATURATED POLYANHYDRIDES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1989-02-09 | — | — | WO | claimed |
| EP-0035886-B1 | SOLID-STATE IMAGING DEVICE HAVING A COLOR FILTER ARRAY AND METHODS OF PREPARING SAME | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1985-11-27 | — | — | EP | claimed |
| US-4489131-A | OXIDIZED POLYOLEFIN, POLYMERIC FILM FORMER, AND ORGANIC ACID; FOR REINFORCING POLYPROPYLENE | OWENS-CORNING FIBERGLAS CORPORATION (US) | 1984-12-18 | — | — | US | claimed |
| EP-0039472-B1 | RADIATION-CROSSLINKABLE POLYESTERS AND POLYESTERETHERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-08-15 | — | — | EP | claimed |
| US-4451592-A | Resin modification for glass fiber adherence | OWENS-CORNING FIBERGLAS CORPORATION (US) | 1984-05-29 | — | — | US | claimed |
| US-4448917-A | POLYOLEFIN RESIN, SILANE, POLYMER FILM FORMER, ORGANIC ACID | OWENS-CORNING FIBERGLAS CORPORATION (US) | 1984-05-15 | — | — | US | claimed |
| US-4315978-A | Solid-state color imaging device having a color filter array using a photocrosslinkable barrier | EASTMAN KODAK COMPANY (US) | 1982-02-16 | — | — | US | claimed |
| EP-0039472-A1 | Radiation-crosslinkable polyesters and polyesterethers | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-11-11 | — | — | EP | claimed |
| EP-0035886-A2 | Solid-state imaging device having a color filter array and methods of preparing same | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1981-09-16 | — | — | EP | claimed |
| US-4284710-A | FROM DIEPOXIDE AND AROMATIC UNSATURATED DICARBOXYLIC ACID OR HYDROXY ACID | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-08-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130165441-A1 | Novel Polymorphs and Salts | PRKDC, PRKACA, MAP3K20 | NFKB1 1960/4885CA1 3614/4885CA2 977/4885 |
| US-20160237073-A1 | Novel Polymorphs and Salts | PRKDC, PRKACA, MAP3K20 | NFKB1 1960/4885CA1 3614/4885CA2 977/4885 |
| US-20140256721-A1 | Novel Polymorphs and Salts | PRKDC, PRKACA, MAP3K20 | NFKB1 1960/4885CA1 3614/4885CA2 977/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.